Steady Expansion Forecast for Medical Bionic Implant/Artificial Organs Market, Projected to Reach $34.89 Billion by 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Medical Bionic Implant/Artificial Organs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for medical bionic implants and artificial organs has seen a robust growth lately. This market is projected to escalate from $23.71 billion in 2024 to a whopping $25.41 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The remarkable expansion witnessed in the past can be accredited to factors like the rising geriatric population, advancements in materials science, government backing and funds, growing receptivity towards implantable devices, and increased patient awareness and education.

Medical Bionic Implant/Artificial Organs Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market for medical bionic implants/artificial organs is predicted to witness robust growth. The market is anticipated to reach $34.89 billion by 2029, increasing at a Compound Annual Growth Rate (CAGR) of 8.2%. Factors such as advancements in bioprinting and tissue engineering, the arrival of biohybrid implants, concentration on cardiac bionics, improved sensory feedback, and the application of regenerative medicine in bionics contribute to this growth during the forecast period. Key trends expected during this period encompass progress in prosthetics and orthotics, an escalating emphasis on brain-machine interfaces (BMIS), the use of bionic organs for transplantation, the application of 3D printing in bionic implants, and the incorporation of artificial intelligence (AI), wireless connectivity, and remote monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/medical-bionic-implant-or-artificial-organs-global-market-report

What Are the Drivers Transforming the Medical Bionic Implant/Artificial Organs Market?
The escalating incidence of road mishaps and injuries is projected to fuel the expansion of the medical bionic implant/artificial organs market. The term 'road accidents and injuries' pertains to an episode on a public thoroughfare leading to accidents and subsequent harm to the victim. Replacement of artificial organs and tissues is typically conducted to rectify organ damage primarily caused by traumatic events like car crashes, violent crimes, occupational injuries, or complex childbirths. For example, the National Highway Traffic Safety Administration, a United States federal government agency specializing in transport safety, reported in May 2022 a 10.5% rise in deaths caused by vehicular crashes, which equates to roughly 42,915 fatalities, compared to the 38,824 witnessed in the past two years. Thus, the surge in road accidents and injuries is propelling the growth of the medical bionic implant/artificial organs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7870&type=smp

What Long-Term Trends Will Define the Future of the Medical Bionic Implant/Artificial Organs Market?
A rising trend in the medical bionic implant/artificial organs market is the increased adoption of strategic alliances. Numerous enterprises active in this market are engaging in collaborations to consolidate their market stance. For instance, Beta Bionics, a US-based producer of medical equipment, and Abbott Laboratories, a US-based medical device firm, teamed up in September 2024 to assimilate the iLet Bionic Pancreas with the FreeStyle Libre 3 continuous glucose monitoring (CGM) system. This union aims to improve the management of diabetes for iLet Bionic Pancreas users through the smooth integration of Abbott's advanced CGM technology. Additionally, in February 2022, HUMOTECH, a US-based company conducting artificial organ research services, partnered with the University of Michigan, a public research university in the US. Their goal is to expedite the progress of bionic leg control software that could potentially provide prosthetic users with the power and natural stride of a human leg. In this collaboration, HUMOTECH is tasked with creating improved versions of the open-source leg for the benefit of prosthesis users and researchers.

Which Segments in the Medical Bionic Implant/Artificial Organs Market Offer the Most Profit Potential?
The medical bionic implant/artificial organs market covered in this report is segmented -

1) By Type: Bionic Implants, Artificial Organs
2) By Method Of Fixation: Implantable, Externally Worn
3) By Technology: Electronic, Mechanical
4) By Application: Hospitals, Clinics, Research And Academic Institutes, Other Applications

Subsegments:
1) By Bionic Implants: Bionic Limbs, Bionic Eyes, Cochlear Implants, Artificial Organs
2) By Artificial Organs: Artificial Hearts, Artificial Kidneys, Artificial Livers, Artificial Pancreas

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7870&type=smp

Which Firms Dominate the Medical Bionic Implant/Artificial Organs Market by Market Share and Revenue in 2025?
Major companies operating in the medical bionic implant/artificial organs market are Medtronic PLC, Boston Scientific Services Private Limited., Abbott Laboratories Inc., Zimmer Biomet Holdings Inc., Ekso Bionics Holdings Inc., Cochlear Limited, Cyberonics Inc., LivaNova PLC, NeuroPace Inc., Ossur India Private Limited, Vivani Medical Inc., St Jude Medical India Private Limited, LifeNet Health Inc., Ottobock SE & Co. KGaA, Edwards Lifesciences India Pvt. Ltd., SynCardia Systems LLC, Demant A/S, Berlin Heart GmbH, Conmed Devices Private Limited, Wright Medical Group N.V., Abiomed Inc., Baxter Laboratories Inc., Asahi Kasei Medical Co. Ltd., Getinge AB, Bornlife Prosthetic and Orthotic Inc., Sonova Holding AG, Biocontrol Medical Ltd., Orthofix International Inc., Aleva Neurotherapeutics SA, Second Sight Medical Products Inc., Touch Bionics Inc., Thoratec Corporation, CardiacAssist Inc., HeartWare International Inc., Synapse Biomedical Inc., Neurotech NA Inc., Retina Implant AG, Advanced Bionics AG, Med-El Elektromedizinische Geräte GmbH

Which Regions Offer the Highest Growth Potential in the Medical Bionic Implant/Artificial Organs Market?
Asia-Pacific was the largest region in the medical bionic implant/artificial organs market share in 2024. The regions covered in the medical bionic implant/artificial organs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7870

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.